Semi-solid Dosage Contract Manufacturing Market Size 2034
Semi-solid Dosage Contract Manufacturing Market Growth, Size, Trends Analysis- By Type, By Product, By End Use, By Company Sizes - Regional Outlook, Competitive Strategies and Segment Forecast to 2034
| Published: Sep-2025 | Report ID: PHAR2528 | Pages: 1 - 246 | Formats*: |
| Category : Pharmaceutical | |||
Semi-solid Dosage Contract Manufacturing Market Introduction and Overview
According to SPER Market Research, the Global Semi-solid Dosage Contract Manufacturing Market is estimated to reach USD 57611.24 million by 2034 with a CAGR 11.48%.
The report includes an in-depth analysis of the Global Semi-solid Dosage Contract Manufacturing Market, including market size and trends, product mix, Applications, and supplier analysis. The global Semi-solid Dosage Contract Manufacturing Market was valued at USD 19,432.9 million in 2024 and is expected to grow at a CAGR of over 11.48% from 2025 to 2034. The growing prevalence of chronic conditions like skin diseases and arthritis, along with the increasing need for pain management due to an aging population, is driving the growth of the semi-solid dosage contract manufacturing market. Creams, ointments, and gels are preferred for their ease of use, especially in treating skin conditions. Contract manufacturing helps pharmaceutical companies reduce costs, accelerate production, and meet regulatory standards. Innovations in formulation, user-friendly packaging, and personalized medicine are enhancing treatment effectiveness. CMOs are also expanding into the cosmetics sector, further boosting market potential and development.
By Type:
The topical segment holds the largest share of the market due to the widespread use of semi-solid forms like ointments, gels, and pastes for targeted drug delivery. These formulations allow direct application to affected areas, minimizing systemic side effects and enhancing treatment effectiveness. Rising cases of skin conditions and chronic diseases, along with innovations in drug delivery, continue to boost demand. Meanwhile, the transdermal segment is growing rapidly, driven by its non-invasive nature, improved patient compliance, and advancements like new patch technologies that enable sustained and effective medication delivery.
By Product:
The creams segment holds the largest market share and is expected to grow the fastest in the coming years. This is due to their effectiveness, ease of application, and high patient compliance. Demand continues to rise with increasing cases of skin conditions like eczema, psoriasis, and acne, alongside growing interest in anti-aging and skincare products. Advances in formulation technologies have improved the penetration, stability, and bioavailability of creams, making them a preferred option for both pharmaceutical and cosmetic applications.
By End Use:
Pharmaceutical companies held the largest market share due to their reliance on contract manufacturers for semi-solid dosage forms, enabling them to reduce costs, meet regulatory standards, and focus on drug development. These partnerships support high-volume production with greater efficiency. Meanwhile, cosmeceutical companies are expected to grow the fastest as they increasingly collaborate with contract manufacturers to meet rising demand for advanced skincare and personal care products. With expertise in complex formulations, CMOs offer the technical capabilities needed to produce creams, serums, and lotions, helping cosmeceutical brands scale production and maintain product quality.
Regional Insights:
The semi-solid dosage contract manufacturing market in North America is expected to experience steady growth, driven by the presence of technologically advanced contract manufacturing organizations. The U.S., with its high healthcare spending and strong government support for research, is home to several leading CMOs known for their expertise and capabilities in semi-solid formulations. Canada also contributes, often focusing on smaller-scale or niche manufacturing needs. Meanwhile, the Asia Pacific region is gaining traction due to its cost-effective manufacturing environment, supported by favorable government policies, lower labor and raw material costs, and a growing pharmaceutical infrastructure, making it a key outsourcing hub globally.
Market Competitive Landscape:
The Semi-solid Dosage Contract Manufacturing Market is highly consolidated. Some of the market key players are Aenova Group, Ajinomoto Bio-Pharma Services, Almac Group, Ascendia Pharmaceuticals, Bora Pharmaceutical CDMO, Cambrex Corporation, Catalent, Inc., Contract Pharmaceuticals Limited, DPT Laboratories, LTD, Lonza Group Ltd., Lubrizol Life Science, MedPharm Ltd.
Recent Developments:
In April 2024, Recipharm announced plans to sell seven manufacturing and development sites in Europe, including semi-solid dosage facilities, to Blue Wolf Capital. The move supports Recipharm’s focus on expanding biologics production, while Blue Wolf is expected to establish a new CDMO with the acquired sites.
In March 2023, Adragos Pharma acquired Clinigen’s Lamda Laboratories, a developer of topical medications, strengthening its capabilities in product development, regulatory affairs, and supply chain management. Lamda will continue focusing on complex formulations for Europe, Japan, and North America.
Scope of the report:
| Report Metric | Details |
| Market size available for years | 2021-2034 |
| Base year considered | 2024 |
| Forecast period | 2025-2034 |
| Segments covered | By Type, By Product, By End Use, By Company Sizes |
| Regions covered | North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa |
| Companies Covered | Aenova Group, Ajinomoto Bio-Pharma Services, Almac Group, Ascendia Pharmaceuticals, Bora Pharmaceutical CDMO, Cambrex Corporation, Catalent, Inc., Contract Pharmaceuticals Limited, DPT Laboratories, LTD, Lonza Group Ltd., Lubrizol Life Science, MedPharm Ltd. |
- Global Semi-solid Dosage Contract Manufacturing Market Size (FY 2021-FY 2034)
- Overview of Global Semi-solid Dosage Contract Manufacturing Market
- Segmentation of Global Semi-solid Dosage Contract Manufacturing Market By Type (Topical, Transdermal, Oral)
- Segmentation of Global Semi-solid Dosage Contract Manufacturing Market By Product (Creams, Ointments, Gels, Lotions, Pastes, Others)
- Segmentation of Global Semi-solid Dosage Contract Manufacturing Market By End Use (Pharmaceutical Companies, Cosmeceutical Companies, Others)
- Segmentation of Global Semi-solid Dosage Contract Manufacturing Market By Company Size (Large Size Companies, Medium & Small Size Companies, Others)
- Statistical Snap of Global Semi-solid Dosage Contract Manufacturing Market
- Expansion Analysis of Global Semi-solid Dosage Contract Manufacturing Market
- Problems and Obstacles in Global Semi-solid Dosage Contract Manufacturing Market
- Competitive Landscape in the Global Semi-solid Dosage Contract Manufacturing Market
- Details on Current Investment in Global Semi-solid Dosage Contract Manufacturing Market
- Competitive Analysis of Global Semi-solid Dosage Contract Manufacturing Market
- Prominent Players in the Global Semi-solid Dosage Contract Manufacturing Market
- SWOT Analysis of Global Semi-solid Dosage Contract Manufacturing Market
- Global Semi-solid Dosage Contract Manufacturing Market Future Outlook and Projections (FY 2025-FY 2034)
- Recommendations from Analyst
1. Introduction
- 1.1. Scope of the report
- 1.2. Market segment analysis
2. Research Methodology
- 2.1. Research data source
- 2.1.1. Secondary Data
- 2.1.2. Primary Data
- 2.1.3. SPERs internal database
- 2.1.4. Premium insight from KOLs
- 2.2. Market size estimation
- 2.2.1. Top-down and Bottom-up approach
- 2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
- 4.1. Driver, Restraint, Opportunity and Challenges analysis
- 4.1.1. Drivers
- 4.1.2. Restraints
- 4.1.3. Opportunities
- 4.1.4. Challenges
5. Market variable and outlook
- 5.1. SWOT Analysis
- 5.1.1. Strengths
- 5.1.2. Weaknesses
- 5.1.3. Opportunities
- 5.1.4. Threats
- 5.2. PESTEL Analysis
- 5.2.1. Political Landscape
- 5.2.2. Economic Landscape
- 5.2.3. Social Landscape
- 5.2.4. Technological Landscape
- 5.2.5. Environmental Landscape
- 5.2.6. Legal Landscape
- 5.3. PORTERs Five Forces
- 5.3.1. Bargaining power of suppliers
- 5.3.2. Bargaining power of buyers
- 5.3.3. Threat of Substitute
- 5.3.4. Threat of new entrant
- 5.3.5. Competitive rivalry
- 5.4. Heat Map Analysis
6. Competitive Landscape
- 6.1. Global Semi-solid Dosage Contract Manufacturing Market Manufacturing Base Distribution, Sales Area, Product Type
- 6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Semi-solid Dosage Contract Manufacturing Market
7. Global Semi-solid Dosage Contract Manufacturing Market, By Type, (USD Million) 2021-2034
- 7.1. Topical
- 7.2. Transdermal
- 7.3. Oral
8. Global Semi-solid Dosage Contract Manufacturing Market, By Product, (USD Million) 2021-2034
- 8.1. Creams
- 8.2. Ointments
- 8.3. Gels
- 8.4. Lotions
- 8.5. Pastes
- 8.6. Others
9. Global Semi-solid Dosage Contract Manufacturing Market, By End Use, (USD Million) 2021-2034
- 9.1. Pharmaceutical Companies
- 9.2. Cosmeceutical Companies
- 9.3. Others
10. Global Semi-solid Dosage Contract Manufacturing Market, By Company Size, (USD Million) 2021-2034
- 10.1. Large Size Companies
- 10.2. Medium & Small Size Companies
- 10.3. Others
11. Global Semi-solid Dosage Contract Manufacturing Market, (USD Million) 2021-2034
- 11.1. Global Semi-solid Dosage Contract Manufacturing Market Size and Market Share
12. Global Semi-solid Dosage Contract Manufacturing Market, By Region, 2021-2034 (USD Million)
- 12.1. Asia-Pacific
- 12.1.1. Australia
- 12.1.2. China
- 12.1.3. India
- 12.1.4. Japan
- 12.1.5. South Korea
- 12.1.6. Rest of Asia-Pacific
- 12.2. Europe
- 12.2.1. France
- 12.2.2. Germany
- 12.2.3. Italy
- 12.2.4. Spain
- 12.2.5. United Kingdom
- 12.2.6. Rest of Europe
- 12.3. Middle East and Africa
- 12.3.1. Kingdom of Saudi Arabia
- 12.3.2. United Arab Emirates
- 12.3.3. Qatar
- 12.3.4. South Africa
- 12.3.5. Egypt
- 12.3.6. Morocco
- 12.3.7. Nigeria
- 12.3.8. Rest of Middle-East and Africa
- 12.4. North America
- 12.4.1. Canada
- 12.4.2. Mexico
- 12.4.3. United States
- 12.5. Latin America
- 12.5.1. Argentina
- 12.5.2. Brazil
- 12.5.3. Rest of Latin America
13. Company Profile
- 13.1. Aenova Group
- 13.1.1. Company details
- 13.1.2. Financial outlook
- 13.1.3. Product summary
- 13.1.4. Recent developments
- 13.2. Ajinomoto Bio-Pharma Services
- 13.2.1. Company details
- 13.2.2. Financial outlook
- 13.2.3. Product summary
- 13.2.4. Recent developments
- 13.3. Almac Group
- 13.3.1. Company details
- 13.3.2. Financial outlook
- 13.3.3. Product summary
- 13.3.4. Recent developments
- 13.4. Ascendia Pharmaceuticals
- 13.4.1. Company details
- 13.4.2. Financial outlook
- 13.4.3. Product summary
- 13.4.4. Recent developments
- 13.5. Bora Pharmaceutical CDMO
- 13.5.1. Company details
- 13.5.2. Financial outlook
- 13.5.3. Product summary
- 13.5.4. Recent developments
- 13.6. Cambrex Corporation
- 13.6.1. Company details
- 13.6.2. Financial outlook
- 13.6.3. Product summary
- 13.6.4. Recent developments
- 13.7. Catalent, Inc.
- 13.7.1. Company details
- 13.7.2. Financial outlook
- 13.7.3. Product summary
- 13.7.4. Recent developments
- 13.8. Contract Pharmaceuticals Limited
- 13.8.1. Company details
- 13.8.2. Financial outlook
- 13.8.3. Product summary
- 13.8.4. Recent developments
- 13.9. DPT Laboratories, LTD
- 13.9.1. Company details
- 13.9.2. Financial outlook
- 13.9.3. Product summary
- 13.9.4. Recent developments
- 13.10. Lonza Group Ltd.
- 13.10.1. Company details
- 13.10.2. Financial outlook
- 13.10.3. Product summary
- 13.10.4. Recent developments
- 13.11. Lubrizol Life Science
- 13.11.1. Company details
- 13.11.2. Financial outlook
- 13.11.3. Product summary
- 13.11.4. Recent developments
- 13.12. MedPharm Ltd
- 13.12.1. Company details
- 13.12.2. Financial outlook
- 13.12.3. Product summary
- 13.12.4. Recent developments
- 13.13. Others
14. Conclusion
15. List of Abbreviations
16. Reference Links
SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.
The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.
Frequently Asked Questions About This Report
Semi-solid Dosage Contract Manufacturing Market grew in Market size from 2025. The Market is expected to reach USD 57611.24 million by 2034, at a CAGR of 11.48% during the forecast period.
Semi-solid Dosage Contract Manufacturing Market CAGR of 11.48% during the forecast period.
You can get the sample pages by clicking the link - Click Here
Semi-solid Dosage Contract Manufacturing Market size is USD 57611.24 million from 2025 to 2034.
Semi-solid Dosage Contract Manufacturing Market is covered By Type, By Product, By End Use, By Company Sizes
The North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa is the highest Market share in the Semi-solid Dosage Contract Manufacturing Market.
Semi-solid Dosage Contract Manufacturing Market is projected to reach USD 57611.24 million by 2034, growing at a CAGR of of 11.48% during the forecast period.
Aenova Group, Ajinomoto Bio-Pharma Services, Almac Group, Ascendia Pharmaceuticals, Bora Pharmaceutical CDMO, Cambrex Corporation, Catalent, Inc., Contract Pharmaceuticals Limited, DPT Laboratories, LTD, Lonza Group Ltd., Lubrizol Life Science, MedPharm Ltd.
The report includes an in-depth analysis of the Global Semi-solid Dosage Contract Manufacturing Market, including market size and trends, product mix, Applications, and supplier analysis.
PLACE AN ORDER
Year End Discount
Sample Report
Pre-Purchase Inquiry
NEED CUSTOMIZATION?
Request CustomizationCALL OR EMAIL US
100% Secure Payment
Related Reports
Have a glance of the Report
Our Global Clients
Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.
